Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...

The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...

Parkinson's Disease Research: Parkinson's disease is a chronic neurological disorder that affects body movement. Let us tell ...

Technological advances and growing investments in stem cell research by private entities and governments enhance therapeutic ...

A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

Two early-stage clinical trials demonstrate the safety and potential effectiveness of stem cell therapies to treat Parkinson’s disease (PD), the second most common neurological disease worldwide. PD ...

Real-time dynamic image analysis delivers detailed concentration measurements critical for distinguishing stem cell populations from debris.

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

North America leads the global cord blood banking services market, holding a 39.54% share in 2025. Growing awareness of stem cell preservation, expanding applications in hematological and genetic ...

On 6 March 2026, Japan approved the world’s first iPS stem cell treatments for Parkinson’s and severe heart failure. Could ...